Search for: "Abbvie, Inc." Results 101 - 120 of 143
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Dec 2021, 12:15 pm by Simmons Hanly Conroy
She recommended that Teva and its subsidiaries receive 50 percent of liability and Anda, Inc., the other 50 percent. [read post]
11 Apr 2016, 2:38 am
Advocate General delivers opinion in United Video Properties, Inc v Telenet NV, C-57/15. [read post]
1 Mar 2014, 6:22 am by Legal Reader
(“Plaintiff”), residing in Johnstown, Pennsylvania, by and through his undersigned counsel, hereby sues Defendants AbbVie Inc. and Abbott Laboratories, Inc. [read post]
19 Jan 2024, 4:00 am by Alan Macek
” In the recent decision, AbbVie Corporation v. [read post]
12 Apr 2020, 6:03 am by Kluwer Patent blogger
” Israel invoked an emergency patent-suspension clause, allowing it to import a generic version of anti-viral drug Kaletra produced by AbbVie Inc. [read post]
12 Jan 2015, 10:24 am by Ed. Microjuris.com Puerto Rico
Thompson, gerente de planta de AbbVie Jayuya y Expresidenta – Waleska Rivera, presidenta y CEO de Danosa Caribbean Inc. [read post]
13 Feb 2014, 8:36 am by m zamora
The following products treat low testosterone:Androderm (Actavis) – patch applied to the skinAndroGel (AbbVie Inc.) [read post]
30 Jul 2021, 7:01 am by Simmons Hanly Conroy
The New York State opioid trial continues against three major drugmakers, Endo International Plc., Teva Pharmaceutical Industries Ltd., and AbbVie Inc’s Allergan unit, which all stand accused of having deceptively marketed their opioid painkillers. [read post]
16 Sep 2021, 12:57 pm by Simmons Hanly Conroy
” The New York State trial is expected to continue into October with remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
11 Mar 2014, 6:58 am by Noble McIntyre
  by  Vall d’Hebron Research Institute (VHIR)  A lawsuit was filed last month against Abbott Laboratories and AbbVie, Inc., which manufacture AndroGel, which claims that the heart risks associated with the treatment have been downplayed. [read post]
25 Apr 2016, 5:00 am
| Actavis v Lilly | EU public consultation on neighbouring rights | Life as an IP Lawyer in San Francisco | Copyright in chess games | Trade surplus and IP | Fujifilm Kyowa Biologics v AbbVie Biotechnology. [read post]